PharmaNutra SpA (IT:PHN) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
PharmaNutra S.p.A. has reported another impressive quarter, showcasing a 17% increase in sales revenues, reaching €83.5 million, and a 27.2% rise in EBITDA compared to the same period last year. The company’s strategic focus on research, development, and innovation has been instrumental in maintaining its growth trajectory. With significant gains in both domestic and international markets, PharmaNutra continues to strengthen its position in the nutritional supplements and medical devices industry.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.